Betamethasone cream 15g

Composition
active ingredients: betamethasone, cetylpyridinium;

1 g of cream contains: betamethasone valerate 1.22 mg, cetylpyridinium chloride 4 mg;

excipients: propylene glycol, mineral oil, cetostearyl alcohol, disodium edetate, purified water.

Pharmacotherapeutic group
Active corticosteroids in combination with antiseptics. Betamethasone and antiseptics. ATC code: D07B CO1.

Indications
Reduction of inflammatory manifestations of dermatoses sensitive to glucocorticosteroid therapy, such as: eczema (atopic, nummular), neurodermatitis, dermatitis (contact, solar, seborrheic, exfoliative, radiation, intertriginous, stasis dermatitis), psoriasis (except widespread psoriasis), anogenital and senile pruritus.

Method of application and dosage
The drug is used externally. The cream is applied in a thin layer to the affected skin surface 1–3 times a day, depending on the severity of the condition. The frequency of application depends on the degree of damage: with a mild degree, the drug can be applied 1 time per day, in case of severe lesions, the frequency of application of the drug must be increased. In most cases, applying the drug 1–2 times a day is sufficient to achieve the effect.

The drug should not be used under occlusive dressings, as side effects may increase.

Continuous use of the drug should not exceed 4 weeks. If the patient’s condition does not improve or worsens within 2–4 weeks of therapy, a re-examination should be performed and the treatment should be reviewed.

Careful monitoring of the development of signs and symptoms of systemic effects of the drug is recommended.

Specific antibacterial therapy should be used for dermatoses associated with bacterial infection.

Patients with dermatoses of fungal origin require special treatment.